Loading...
Probing the PI3K/mTOR Pathway in Gliomas: A Phase II Study of Everolimus for Recurrent Adult Low Grade Gliomas
BACKGROUND: Activation of the PI3K/mTOR pathway is common in patients with low-grade gliomas (LGG), but agents that inhibit this pathway, including mTOR inhibitors, have not been studied in this population. METHODS: 58 patients with pathologic evidence of recurrence after initially diagnosed WHO gra...
Na minha lista:
| Udgivet i: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693663/ https://ncbi.nlm.nih.gov/pubmed/28759109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30909 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|